Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


COMMENT: How blood cancers could be diagnosed and treated earlier

This article was originally published in Clinica

Executive Summary

Hematological cancers are the only cancers where the matrix in which the tumour cells reside is accessible without a biopsy. Coupling this with the maturation of longitudinal serum banks allows the study of biomarkers and targets in pre-disease samples and of the development of disease from a healthy state through to cancer formation. Such studies could support earlier diagnosis and treatment, which may ultimately improve survival, writes Mike Fisher and Wendy Alderton





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts